{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"oncogenic-osteomalacia","columns":[{"gene":"","key":"population-d9a7bd6536894fb9f676","label":"Oncogenic osteomalacia","mondoId":"MONDO:0018124","onsetQualifier":null,"originColumnKey":"MONDO:0018124/ORPHA:352540","originalViews":[{"key":"MONDO:0018124/ORPHA:352540","label":"Oncogenic osteomalacia","scopeLabel":"ORPHA:352540","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["0184af56008827fa3101bf8d6eac7b7bb09ffb18181df004a87583c45302eb58","07bf4e075d2620324e6c4b8d497a627abbaf38f616c4ba88066129e77a3d4d66","0a3d9c6f1250a31ec3b2585aa4ff37537f3958711c411da7daca92179345f125","0e07931b27f6588dc8f7e3aaaf18cae8d65de3fb12acd3453185b1ac4e3e048d","12e2853f35b46dffce6be19c30b9179755dca74fc6e6922174d1c9836e7ace42","16aff455858cbdd1f81d50e7ab4ef815db1bf3de9976c960138ea9fa00714aad","179dac678cc0e9a8d6d51852c1d224922bc49864c6f8fe0160a8623b611964a6","202ab74a949cd74ee75b71f8d8723e42c0e980c576f79f133ab8833665ac1d01","263a60a842c8edb62fc76e87690acab8989e4c1480676ebc5a03e18625cfa1cb","29402449c938c7babaa4caa7ac68a1c71262cc8ab8f29e0d7ac1490444da598d","3a0087d9537fa81624e7de14bc51db425b28d4ce416da582fd29acf51cda0674","3fee4121611aa9e148614a0aa83f1e46660d31f2daf5e15f42d759d4fe40d539","473387790ec902214abf375ae94c8b3bb33a3997ca5c23b347c545ee1eafa968","590bd8c18fd72fbad2755a9e11baba9c51968604d249cfa0c84d9207aab7de22","5c3637f5a0dd91b95b8aa8a38c4baa3d85648dacedb0728889e40618c93c3633","5e8f11767fff95c29ba2ca15750ed6388ce9e0d239bd14dbff6ca76c6cbb7489","7227d98950f19d9809fddb9767f9aedcf6e7ce43ae05d289cca5c877b3677ff5","86e7bf4d8d7488eb4ff9d10feb9b4b6b46e16a73d41e7d3b487f873cba13fd6b","8af2debb86db271e0406c1f1ae4214e2d4a094736fd129797484beba6881c4e6","92f061881f28fbe23b45f4c0e62120d13523848772c8205bc4e3ca5ec3785da6","98edbc999f25bdd2bb5452ceddfac27d56b80ec759d10eb5f19aab9ba06522fa","a955a68b3c3bf995780d165802cebe876b0a79c16aea8f992ec576d0eac8e0ff","b2649c48e82702d7a36b13d250fe28d259cf4ae4cc67baab2a7e45a505075f5e","ba4cc40f10c08f3157e09e9510dbd770e92c98dd44b1f94b74a3cde2b1798ab7","bbb77cc968c8f7f42fcd3ac2685d2471a044e7be66ba9ca7a973c9c7539d9524","c6e560a11818a44cceb953181db0e86284eadd6c475d5f07829f229463a51c75","c8f7fe42cbe69f1c5cb03df8444e75fe779681f20eb3f05ec15bedb2d8f19345","d2f74ebe511a284173940d500e46ace6966a5fa6262bce365c6ef53a57124acb","d92885c4b67ee1402a15dbe10b89596c1ac8529b96ded2d42777314a41dac19c","dbb15f5e08e0304c121e9765660caeb116c48a077a621c5c4dab8c5143c4ac29","de4103f6fabf6a4524357073c2e44b607ea7615534b6866154a042f6f2b5488e","de77a7467524ab4a3c228976abbe8443a1c825a82af91298b450e305eb9d23a0","e20537cff91579f2ccadf5e415852101db0ac843c0026876a07d021b3168014d","f58f24dd73d0374f376038bf8086de63cc744176fe482f8e5da48b4c72fc1895","f62994faf8aee906e1ff612a1043b8a1632fcec8555b268e455ec9f88de63883"],"recordQualifiers":{},"scopeLabel":"ORPHA:352540","sourceIds":["ORPHA:352540"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-d9a7bd6536894fb9f676"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:6000489","HP:0002823","HP:0002991","HP:0001760","HP:0040163","HP:0003468","HP:0001850"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":35,"sourceGroups":{"orphanet":35}},"features":[{"hpoId":"HP:6000489","label":"Abnormal circulating fibroblast growth factor 23 concentration","primary":true},{"hpoId":"HP:0002823","label":"Abnormal femur morphology","primary":true},{"hpoId":"HP:0002991","label":"Abnormal fibula morphology","primary":true},{"hpoId":"HP:0001760","label":"Abnormal foot morphology","primary":true},{"hpoId":"HP:0040163","label":"Abnormal pelvis bone morphology","primary":true},{"hpoId":"HP:0003468","label":"Abnormal vertebral morphology","primary":true},{"hpoId":"HP:0001850","label":"Abnormality of the tarsal bones","primary":true},{"hpoId":"HP:0002653","label":"Bone pain","primary":false},{"hpoId":"HP:0006487","label":"Bowing of the long bones","primary":false},{"hpoId":"HP:0030731","label":"Carcinoma","primary":false},{"hpoId":"HP:0012052","label":"Decreased circulating calcitriol concentration","primary":false},{"hpoId":"HP:0003155","label":"Elevated circulating alkaline phosphatase concentration","primary":false},{"hpoId":"HP:0010734","label":"Fibrous dysplasia of the bones","primary":false},{"hpoId":"HP:0001288","label":"Gait disturbance","primary":false},{"hpoId":"HP:0011847","label":"Giant cell tumor of bone","primary":false},{"hpoId":"HP:0001510","label":"Growth delay","primary":false},{"hpoId":"HP:0003109","label":"Hyperphosphaturia","primary":false},{"hpoId":"HP:0002901","label":"Hypocalcemia","primary":false},{"hpoId":"HP:0002148","label":"Hypophosphatemia","primary":false},{"hpoId":"HP:0004912","label":"Hypophosphatemic rickets","primary":false},{"hpoId":"HP:0002659","label":"Increased susceptibility to fractures","primary":false},{"hpoId":"HP:0000787","label":"Kidney stone","primary":false},{"hpoId":"HP:0002808","label":"Kyphosis","primary":false},{"hpoId":"HP:0001324","label":"Muscle weakness","primary":false},{"hpoId":"HP:0012288","label":"Neoplasm of head and neck","primary":false},{"hpoId":"HP:0010622","label":"Neoplasm of the skeletal system","primary":false},{"hpoId":"HP:0000121","label":"Nephrocalcinosis","primary":false},{"hpoId":"HP:0002749","label":"Osteomalacia","primary":false},{"hpoId":"HP:0002669","label":"Osteosarcoma","primary":false},{"hpoId":"HP:0002756","label":"Pathologic fracture","primary":false},{"hpoId":"HP:0000768","label":"Pectus carinatum","primary":false},{"hpoId":"HP:0003701","label":"Proximal muscle weakness","primary":false},{"hpoId":"HP:0000117","label":"Renal phosphate wasting","primary":false},{"hpoId":"HP:0002093","label":"Respiratory insufficiency","primary":false},{"hpoId":"HP:0002982","label":"Tibial bowing","primary":false}],"ledeHtml":"Oncogenic osteomalacia is characterized by the development of a tumor that causes the bones to be weakened. This occurs when a tumor secretes a substance called fibroblast growth factor 23 (FGF23). FGF23 inhibits the ability of the kidneys to absorb phosphate. Phosphate is important for keeping bones strong and healthy. Therefore, this disease is characterized by a softening and weakening of the bones (osteomalacia). The disease also results in multiple biochemical abnormalities including high levels of phosphate in the urine (hyperphosphaturia) and low levels of phosphate in the blood (hypophosphatemia). The majority of tumors that cause Oncogenic osteomalacia are small and slow-growing. These tumors most commonly occur in the skin, muscles, or bones of the extremities or in the paranasal sinuses around the head. Most of these tumors are benign, meaning they are not associated with cancer. The exact reason that the tumors associated with Oncogenic osteomalacia develop is not known. The disease is diagnosed when a person experiences clinical features such as bone weakening and hyperphosphaturia and a tumor is found by imaging of the body.","mondoId":"MONDO:0018124","node":{"canonicalSlug":"oncogenic-osteomalacia","comparisons":[{"documentSha256":"bf2c888b16095606c63463d8be9e2e6bb0b6bb6413bc8d5fdf4a2b5bddba933e","key":"legacy-oncogenic-osteomalacia","kind":"legacy","label":"Oncogenic osteomalacia","memberIds":["MONDO:0018124"],"mondoId":"MONDO:0018124","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/oncogenic-osteomalacia.bf2c888b16095606c63463d8be9e2e6bb0b6bb6413bc8d5fdf4a2b5bddba933e.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"summary","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Tumor-induced osteomalacia","originalSourceId":"ORPHA:352540","paragraphs":["Oncogenic osteomalacia is characterized by the development of a tumor that causes the bones to be weakened. This occurs when a tumor secretes a substance called fibroblast growth factor 23 (FGF23). FGF23 inhibits the ability of the kidneys to absorb phosphate. Phosphate is important for keeping bones strong and healthy. Therefore, this disease is characterized by a softening and weakening of the bones (osteomalacia). The disease also results in multiple biochemical abnormalities including high levels of phosphate in the urine (hyperphosphaturia) and low levels of phosphate in the blood (hypophosphatemia). The majority of tumors that cause Oncogenic osteomalacia are small and slow-growing. These tumors most commonly occur in the skin, muscles, or bones of the extremities or in the paranasal sinuses around the head. Most of these tumors are benign, meaning they are not associated with cancer. The exact reason that the tumors associated with Oncogenic osteomalacia develop is not known. The disease is diagnosed when a person experiences clinical features such as bone weakening and hyperphosphaturia and a tumor is found by imaging of the body."],"rawAttribution":"MONDO:0018124","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-21T17:06:38Z","upstream":"GARD:0009652","url":"https://rarediseases.info.nih.gov/diseases/9652"},"ownColumnKeys":["population-d9a7bd6536894fb9f676"],"publication":"published","relationships":[{"kind":"parent","label":"osteomalacia","mondoId":"MONDO:0001068","slug":null},{"kind":"parent","label":"parneoplastic endocrine syndrome","mondoId":"MONDO:0700252","slug":null},{"kind":"parent","label":"paraneoplastic renal syndrome","mondoId":"MONDO:0700255","slug":null}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending"},"records":[{"frequencyKind":"range","key":"0184af56008827fa3101bf8d6eac7b7bb09ffb18181df004a87583c45302eb58","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:352540","disease_name":"Oncogenic osteomalacia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002901","is_excluded":false,"label":"Hypocalcemia","onset_id":null,"reference":"ORPHA:352540","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"07bf4e075d2620324e6c4b8d497a627abbaf38f616c4ba88066129e77a3d4d66","raw":{"aspect":"P","body_system":"neoplasm","disease_id":"ORPHA:352540","disease_name":"Oncogenic osteomalacia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0010622","is_excluded":false,"label":"Neoplasm of the skeletal system","onset_id":null,"reference":"ORPHA:352540","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"0a3d9c6f1250a31ec3b2585aa4ff37537f3958711c411da7daca92179345f125","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:352540","disease_name":"Oncogenic osteomalacia","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0003109","is_excluded":false,"label":"Hyperphosphaturia","onset_id":null,"reference":"ORPHA:352540","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"0e07931b27f6588dc8f7e3aaaf18cae8d65de3fb12acd3453185b1ac4e3e048d","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:352540","disease_name":"Oncogenic osteomalacia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0040163","is_excluded":false,"label":"Abnormal pelvis bone morphology","onset_id":null,"reference":"ORPHA:352540","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"12e2853f35b46dffce6be19c30b9179755dca74fc6e6922174d1c9836e7ace42","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:352540","disease_name":"Oncogenic osteomalacia","evidence":"TAS","frequency_raw":"HP:0040284","hpo_id":"HP:0003468","is_excluded":false,"label":"Abnormal vertebral morphology","onset_id":null,"reference":"ORPHA:352540","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"16aff455858cbdd1f81d50e7ab4ef815db1bf3de9976c960138ea9fa00714aad","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:352540","disease_name":"Oncogenic osteomalacia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:6000489","is_excluded":false,"label":"Abnormal circulating fibroblast growth factor 23 concentration","onset_id":null,"reference":"ORPHA:352540","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"179dac678cc0e9a8d6d51852c1d224922bc49864c6f8fe0160a8623b611964a6","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:352540","disease_name":"Oncogenic osteomalacia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002749","is_excluded":false,"label":"Osteomalacia","onset_id":null,"reference":"ORPHA:352540","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"202ab74a949cd74ee75b71f8d8723e42c0e980c576f79f133ab8833665ac1d01","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:352540","disease_name":"Oncogenic osteomalacia","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001324","is_excluded":false,"label":"Muscle weakness","onset_id":null,"reference":"ORPHA:352540","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"263a60a842c8edb62fc76e87690acab8989e4c1480676ebc5a03e18625cfa1cb","raw":{"aspect":"P","body_system":"neoplasm","disease_id":"ORPHA:352540","disease_name":"Oncogenic osteomalacia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002669","is_excluded":false,"label":"Osteosarcoma","onset_id":null,"reference":"ORPHA:352540","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"29402449c938c7babaa4caa7ac68a1c71262cc8ab8f29e0d7ac1490444da598d","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:352540","disease_name":"Oncogenic osteomalacia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002808","is_excluded":false,"label":"Kyphosis","onset_id":null,"reference":"ORPHA:352540","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"3a0087d9537fa81624e7de14bc51db425b28d4ce416da582fd29acf51cda0674","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:352540","disease_name":"Oncogenic osteomalacia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000768","is_excluded":false,"label":"Pectus carinatum","onset_id":null,"reference":"ORPHA:352540","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"3fee4121611aa9e148614a0aa83f1e46660d31f2daf5e15f42d759d4fe40d539","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:352540","disease_name":"Oncogenic osteomalacia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0010734","is_excluded":false,"label":"Fibrous dysplasia of the bones","onset_id":null,"reference":"ORPHA:352540","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"473387790ec902214abf375ae94c8b3bb33a3997ca5c23b347c545ee1eafa968","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:352540","disease_name":"Oncogenic osteomalacia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002982","is_excluded":false,"label":"Tibial bowing","onset_id":null,"reference":"ORPHA:352540","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"590bd8c18fd72fbad2755a9e11baba9c51968604d249cfa0c84d9207aab7de22","raw":{"aspect":"P","body_system":"neoplasm","disease_id":"ORPHA:352540","disease_name":"Oncogenic osteomalacia","evidence":"TAS","frequency_raw":"HP:0040284","hpo_id":"HP:0030731","is_excluded":false,"label":"Carcinoma","onset_id":null,"reference":"ORPHA:352540","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"5c3637f5a0dd91b95b8aa8a38c4baa3d85648dacedb0728889e40618c93c3633","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:352540","disease_name":"Oncogenic osteomalacia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001288","is_excluded":false,"label":"Gait disturbance","onset_id":null,"reference":"ORPHA:352540","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"5e8f11767fff95c29ba2ca15750ed6388ce9e0d239bd14dbff6ca76c6cbb7489","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:352540","disease_name":"Oncogenic osteomalacia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002823","is_excluded":false,"label":"Abnormal femur morphology","onset_id":null,"reference":"ORPHA:352540","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"7227d98950f19d9809fddb9767f9aedcf6e7ce43ae05d289cca5c877b3677ff5","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:352540","disease_name":"Oncogenic osteomalacia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0012052","is_excluded":false,"label":"Decreased circulating calcitriol concentration","onset_id":null,"reference":"ORPHA:352540","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"86e7bf4d8d7488eb4ff9d10feb9b4b6b46e16a73d41e7d3b487f873cba13fd6b","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:352540","disease_name":"Oncogenic osteomalacia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002653","is_excluded":false,"label":"Bone pain","onset_id":null,"reference":"ORPHA:352540","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"8af2debb86db271e0406c1f1ae4214e2d4a094736fd129797484beba6881c4e6","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:352540","disease_name":"Oncogenic osteomalacia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0003701","is_excluded":false,"label":"Proximal muscle weakness","onset_id":null,"reference":"ORPHA:352540","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"92f061881f28fbe23b45f4c0e62120d13523848772c8205bc4e3ca5ec3785da6","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:352540","disease_name":"Oncogenic osteomalacia","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000117","is_excluded":false,"label":"Renal phosphate wasting","onset_id":null,"reference":"ORPHA:352540","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"98edbc999f25bdd2bb5452ceddfac27d56b80ec759d10eb5f19aab9ba06522fa","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:352540","disease_name":"Oncogenic osteomalacia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002659","is_excluded":false,"label":"Increased susceptibility to fractures","onset_id":null,"reference":"ORPHA:352540","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"a955a68b3c3bf995780d165802cebe876b0a79c16aea8f992ec576d0eac8e0ff","raw":{"aspect":"P","body_system":"respiratory","disease_id":"ORPHA:352540","disease_name":"Oncogenic osteomalacia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002093","is_excluded":false,"label":"Respiratory insufficiency","onset_id":null,"reference":"ORPHA:352540","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"b2649c48e82702d7a36b13d250fe28d259cf4ae4cc67baab2a7e45a505075f5e","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:352540","disease_name":"Oncogenic osteomalacia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002991","is_excluded":false,"label":"Abnormal fibula morphology","onset_id":null,"reference":"ORPHA:352540","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"ba4cc40f10c08f3157e09e9510dbd770e92c98dd44b1f94b74a3cde2b1798ab7","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:352540","disease_name":"Oncogenic osteomalacia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001850","is_excluded":false,"label":"Abnormality of the tarsal bones","onset_id":null,"reference":"ORPHA:352540","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"bbb77cc968c8f7f42fcd3ac2685d2471a044e7be66ba9ca7a973c9c7539d9524","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:352540","disease_name":"Oncogenic osteomalacia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000121","is_excluded":false,"label":"Nephrocalcinosis","onset_id":null,"reference":"ORPHA:352540","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"c6e560a11818a44cceb953181db0e86284eadd6c475d5f07829f229463a51c75","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:352540","disease_name":"Oncogenic osteomalacia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0006487","is_excluded":false,"label":"Bowing of the long bones","onset_id":null,"reference":"ORPHA:352540","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"c8f7fe42cbe69f1c5cb03df8444e75fe779681f20eb3f05ec15bedb2d8f19345","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:352540","disease_name":"Oncogenic osteomalacia","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0002148","is_excluded":false,"label":"Hypophosphatemia","onset_id":null,"reference":"ORPHA:352540","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"d2f74ebe511a284173940d500e46ace6966a5fa6262bce365c6ef53a57124acb","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:352540","disease_name":"Oncogenic osteomalacia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0004912","is_excluded":false,"label":"Hypophosphatemic rickets","onset_id":null,"reference":"ORPHA:352540","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"d92885c4b67ee1402a15dbe10b89596c1ac8529b96ded2d42777314a41dac19c","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:352540","disease_name":"Oncogenic osteomalacia","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0003155","is_excluded":false,"label":"Elevated circulating alkaline phosphatase concentration","onset_id":null,"reference":"ORPHA:352540","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"dbb15f5e08e0304c121e9765660caeb116c48a077a621c5c4dab8c5143c4ac29","raw":{"aspect":"P","body_system":"neoplasm","disease_id":"ORPHA:352540","disease_name":"Oncogenic osteomalacia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0012288","is_excluded":false,"label":"Neoplasm of head and neck","onset_id":null,"reference":"ORPHA:352540","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"de4103f6fabf6a4524357073c2e44b607ea7615534b6866154a042f6f2b5488e","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:352540","disease_name":"Oncogenic osteomalacia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000787","is_excluded":false,"label":"Kidney stone","onset_id":null,"reference":"ORPHA:352540","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"de77a7467524ab4a3c228976abbe8443a1c825a82af91298b450e305eb9d23a0","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:352540","disease_name":"Oncogenic osteomalacia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001760","is_excluded":false,"label":"Abnormal foot morphology","onset_id":null,"reference":"ORPHA:352540","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"e20537cff91579f2ccadf5e415852101db0ac843c0026876a07d021b3168014d","raw":{"aspect":"P","body_system":"growth","disease_id":"ORPHA:352540","disease_name":"Oncogenic osteomalacia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001510","is_excluded":false,"label":"Growth delay","onset_id":null,"reference":"ORPHA:352540","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"f58f24dd73d0374f376038bf8086de63cc744176fe482f8e5da48b4c72fc1895","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:352540","disease_name":"Oncogenic osteomalacia","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0002756","is_excluded":false,"label":"Pathologic fracture","onset_id":null,"reference":"ORPHA:352540","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"f62994faf8aee906e1ff612a1043b8a1632fcec8555b268e455ec9f88de63883","raw":{"aspect":"P","body_system":"neoplasm","disease_id":"ORPHA:352540","disease_name":"Oncogenic osteomalacia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0011847","is_excluded":false,"label":"Giant cell tumor of bone","onset_id":null,"reference":"ORPHA:352540","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/9652\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0018124\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>GARD:0009652</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Oncogenic osteomalacia is characterized by the development of a tumor that causes the bones to be weakened. This occurs when a tumor secretes a substance called fibroblast growth factor 23 (FGF23). FGF23 inhibits the ability of the kidneys to absorb phosphate. Phosphate is important for keeping bones strong and healthy. Therefore, this disease is characterized by a softening and weakening of the bones (osteomalacia). The disease also results in multiple biochemical abnormalities including high levels of phosphate in the urine (hyperphosphaturia) and low levels of phosphate in the blood (hypophosphatemia). The majority of tumors that cause Oncogenic osteomalacia are small and slow-growing. These tumors most commonly occur in the skin, muscles, or bones of the extremities or in the paranasal sinuses around the head. Most of these tumors are benign, meaning they are not associated with cancer. The exact reason that the tumors associated with Oncogenic osteomalacia develop is not known. The disease is diagnosed when a person experiences clinical features such as bone weakening and hyperphosphaturia and a tumor is found by imaging of the body.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/9652\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Overview"}],"sharedSources":[],"slug":"oncogenic-osteomalacia","sourceDocuments":[{"name":"GARD: Tumor-induced osteomalacia","reviewed":null,"source_release":"2026-10-21T17:06:38Z","url":"https://rarediseases.info.nih.gov/diseases/9652"},{"name":"MONDO: Oncogenic osteomalacia","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0018124"}],"sourceNote":"","synonyms":["Oncogenic hypophosphatemic osteomalacia","OO","OOM","TIO","tumor-induced osteomalacia"],"takeawayHtml":"","title":"Oncogenic osteomalacia"},"schemaVersion":1}
